Reported Standalone quarterly numbers for Transgene Biotek are:
Net Sales at Rs 0.08 crore in December 2024 up 70% from Rs. 0.05 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.09 crore in December 2024 up 25.27% from Rs. 0.12 crore in December 2023.
EBITDA stands negative at Rs. 0.05 crore in December 2024 up 28.57% from Rs. 0.07 crore in December 2023.
Transgene Biote shares closed at 4.56 on January 24, 2025 (BSE) and has given -53.56% returns over the last 6 months and -61.19% over the last 12 months.
Story continues below Advertisement
| Transgene Biotek | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | | Net Sales/Income from operations | 0.08 | 0.06 | 0.05 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 0.08 | 0.06 | 0.05 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | 0.00 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.08 | 0.08 | 0.08 | | Depreciation | 0.02 | 0.02 | 0.02 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.09 | 0.05 | 0.08 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.12 | -0.10 | -0.13 | | Other Income | 0.04 | 0.04 | 0.04 | | P/L Before Int., Excpt. Items & Tax | -0.07 | -0.06 | -0.09 | | Interest | 0.02 | 0.02 | 0.03 | | P/L Before Exceptional Items & Tax | -0.09 | -0.07 | -0.12 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.09 | -0.07 | -0.12 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -0.09 | -0.07 | -0.12 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.09 | -0.07 | -0.12 | | Equity Share Capital | 75.77 | 75.77 | 75.77 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.01 | -0.01 | -0.02 | | Diluted EPS | -0.01 | -0.01 | -0.02 | | EPS After Extra Ordinary | | Basic EPS | -0.01 | -0.01 | -0.02 | | Diluted EPS | -0.01 | -0.01 | -0.02 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
